2024

1. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients

   The Lancet Infectious Diseases, Vol. 24, Núm. 1, pp. e59-e68

2. Current management of SARS-CoV-2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey

   Transplant Infectious Disease, Vol. 26, Núm. 2

3. Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice

   Antiviral Research, Vol. 227

4. Donor-Dependent Variations in Systemic Oxidative Stress and Their Association with One-Year Graft Outcomes in Kidney Transplantation

   American journal of nephrology, Vol. 55, Núm. 5, pp. 509-519

5. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

   Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

6. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

   Transplant Infectious Disease

7. How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations

   Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 442-452

8. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

   American Journal of Transplantation, Vol. 24, Núm. 7, pp. 1180-1192

9. Incidence of refractory CMV infection with or without antiviral resistance in Spain: A systematic literature review

   Transplantation Reviews, Vol. 38, Núm. 1

10. Invasive aspergillosis in liver transplant recipients in the current era

    American Journal of Transplantation, Vol. 24, Núm. 11, pp. 2092-2107

11. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

12. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

13. Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients

    Transplant Infectious Disease

14. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

15. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

16. Recurrent Clostridioides difficile infections in solid organ transplant recipients: The international CALIPSO study

    Journal of Infection, Vol. 89, Núm. 6

17. Reduction of Instrumentation-Related Spine Surgical Site Infections After Optimization of Surgical Techniques. A Single Center Retrospective Analysis

    Global Spine Journal, Vol. 14, Núm. 2, pp. 438-446

18. Risk factors for poor outcome in adult patients with respiratory syncytial virus infection evaluated at the emergency department

    Journal of Medical Virology, Vol. 96, Núm. 10

19. Spatial Relationship between a Regional Outbreak and a Higher-than-Expected Incidence of Leishmaniasis in Urban Southern Madrid, Spain

    The American journal of tropical medicine and hygiene, Vol. 111, Núm. 4, pp. 814-818

20. Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram-negative bacteria

    Transplant Infectious Disease, Vol. 26, Núm. 2